ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000235831.2	Ponatinib	Bladder urothelial carcinoma	0.046693153	Resistant
ENSG00000235831.2	Ponatinib	Lung squamous cell carcinoma	0.026815103	Sensitive